The introduction of Rybelsus marked a significant advancement in the treatment landscape for type 2 diabetes. This oral medication contains semaglutide, a GLP-1 receptor agonist that helps manage blood glucose levels effectively. It operates by mimicking the action of incretin hormones, which are involved in glucose metabolism. After meals, these…